Edit |   |
---|---|
Antigenic Specificity | IL6R, Human (Satralizumab biosimilar) |
Clone | Satralizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL6R Recombinant Antibody (Satralizumab). Satralizumab, sold under the brand name Enspryng, is a humanized monoclonal antibody medication that is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. The drug is being developed by Chugai Pharmaceutical, a subsidiary of Roche. |
Immunogen | n/a |
Other Names | Anti-IL6R Recombinant Antibody, Research Grade Satralizumab, Anti-Human IL6R Recombinant Antibody(Satralizumab), SA-237, Antibody Drug Analogues, Monoclonal Antibody, YR1396, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1535963-91-7 |
Catalog # | YR1396 |
Price | please inquire |
Order / More Info | IL6R, Human (Satralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |